Local Institution

Shinjuku-ku, Tokyo 1608582

0 studies enrolling now · 9 studies all time

What they study most

Leukemia, Lupus, Lupus Nephritis, Psoriasis, Rheumatoid Arthritis, Sjogrens Disease

Studies at this site

• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
• An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early
• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis — Completed
• A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome — Completed
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis — Completed